Coherus Oncology (CHRS) Other Non Operating Income (2013 - 2026)
Coherus Oncology's Other Non Operating Income came in at $1.31 million for Q2 2026, down 54.9% from $2.9 million a year earlier and down 6.8% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Other Non Operating Income (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Coherus Oncology reported Other Non Operating Income of $6.63 million, up 28.2% year-over-year; for FY2025, it was $7.01 million.
- Other Non Operating Income carries a five-year compound annual growth rate of 66.1% (FY2020 to FY2025).
- Going back by year, Other Non Operating Income was -$12.63 million in FY2024, $5.47 million in FY2023, -$6.22 million in FY2022 and -$283,000 in FY2021.
- The Q2 2026 figure represents the lowest quarterly Other Non Operating Income since Q1 2025.
- Year-over-year, Other Non Operating Income increased in two of the last five quarters, with growth averaging 99.3%.
- The fastest year-over-year change in Other Non Operating Income over five years came in Q1 2026 (growth of 649.7%), and the weakest in Q1 2025 (a decline of 93.5%).
- Business Quant data shows CHRS's Other Non Operating Income at $1.4 million (Q1 2026), $1.78 million (Q4 2025) and $2.14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | -11.16 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | -129,000.00 |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.62 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 2.01 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 443,000.00 |
| Mar 31, 2022 | -6.19 Mn |
| Dec 31, 2021 | -385,000.00 |
| Sep 30, 2021 | 30,000.00 |
API Access
Coherus Oncology Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();